Academic literature on the topic 'ABOi transplant'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'ABOi transplant.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "ABOi transplant"

1

Xiao, Min, Zhenmiao Wan, Xin Lin, et al. "ABO-Incompatible Liver Transplantation under the Desensitization Protocol with Rituximab: Effect on Biliary Microbiota and Metabolites." Journal of Clinical Medicine 12, no. 1 (2022): 141. http://dx.doi.org/10.3390/jcm12010141.

Full text
Abstract:
Background: ABO-incompatible liver transplantation (ABOi LT) under the desensitization protocol with rituximab had excellent survival outcomes comparable to those of ABO-compatible liver transplantation (ABOc LT). In this work, we explored the effect of ABOi LT on recipients from the perspective of biliary microbiota and metabonomics. Methods: Liver transplant (LT) recipients treated at our center were enrolled in the study. In total, 6 ABOi LT recipients and 12 ABOc LT recipients were enrolled, and we collected their bile five times (during LT and at 2 days, 1 week, 2 weeks and 1 month after
APA, Harvard, Vancouver, ISO, and other styles
2

Pavenski, Katerina, Megan Buchholz, Patti Lou Cheatley, et al. "The First North American Experience Using Glycosorb Immunoadsorption Columns for Blood Group–Incompatible Kidney Transplantation." Canadian Journal of Kidney Health and Disease 7 (January 2020): 205435812096258. http://dx.doi.org/10.1177/2054358120962586.

Full text
Abstract:
Background: Blood group incompatibility (ABOi) is the most common barrier to living donor kidney transplantation. Options for such recipients include kidney paired donation (KPD) or desensitization methodology to reduce blood antibody response. Objective: The objective of this study is to report on the first North America experience in ABOi living donor kidney transplantation using Glycosorb ABO immunoadsorption columns. Design: Retrospective observational cohort study. Setting: Renal transplant program at St. Michael’s Hospital, Unity Health Toronto, University of Toronto. Patients: Twenty-si
APA, Harvard, Vancouver, ISO, and other styles
3

de Magnée, Catherine, Louise Brunée, Roberto Tambucci, et al. "Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?" Children 8, no. 7 (2021): 600. http://dx.doi.org/10.3390/children8070600.

Full text
Abstract:
Background: ABO-incompatible (ABOi) living donor liver transplantation (LDLT) has been proposed to compensate for donor shortage. To date, few studies have reported detailed ABOi LDLT results in large series of pediatric patients. C4d complement deposition in graft capillaries has been reported to be associated with antibody-mediated rejection in solid organ transplantation. Methods: A retrospective case–control study was conducted, comparing clinical outcomes of each of 34 consecutive pediatric ABOi LDLT recipients with those of 2 non-ABOi pairs (n = 68), matched according to pre-transplant d
APA, Harvard, Vancouver, ISO, and other styles
4

Amitkumar, Vishnubhai Prajapati, Vimalbhai Kanodia Kamal, Yuvraj Modi Pooja, Vallabhbhai Patel Himanshu, Bhagwanbhai Vala Kinnari, and Ramanlal Modi Pranjal. "Therapeutic Plasma Exchange as a Pre-Conditioning Regimen in ABO Incompatible Renal Transplant- Experience from Largest Transplant Institute in Gujarat, India." International Journal of Pharmaceutical and Clinical Research 16, no. 12 (2024): 1454–60. https://doi.org/10.5281/zenodo.14613590.

Full text
Abstract:
<strong>Background:&nbsp;</strong>ABO non-identical renal transplantation is becoming increasingly common to overcome the unavailability/ shortage of ABO identical donor(s). This study was conducted to evaluate whether Plasma exchange is an effective method in reducing ABO titers to desired levels in ABO Incompatible renal transplant recipients, as used as a part of desensitization regimen.&nbsp;<strong>Methods:&nbsp;</strong>A retrospective observational analysis was done in 11 patients taken for ABOi renal transplant from February 2022 to April 2024. All the 11 patients were treated with Pla
APA, Harvard, Vancouver, ISO, and other styles
5

Fernando, Meranthi, Suchintha Tillakaratne, Bhagya Gunetilleke, et al. "An ABO-incompatible living donor liver transplant in an infant with acute liver failure in the Sri Lankan setting." Ceylon Medical Journal 68, no. 1 (2023): 25–28. http://dx.doi.org/10.4038/cmj.v68i1.9714.

Full text
Abstract:
Liver transplant (LT) is the standard therapy for medically refractory acute liver failure (ALF). Finding a deceaseddonor graft in an emergency is challenging and often overcome by living-donation. Blood group matching is practised for LT though ABO-incompatible liver transplant (ABOi-LT) is performed inselected circumstances. We report an infant who underwent successful ABOincompatible living donor LT for ALF of unknown aetiology. This being the country’s first ABOi-LT, the youngest LT recipient to date and the youngest receiving emergency LT for ALF; we describe the novel experience at a res
APA, Harvard, Vancouver, ISO, and other styles
6

Lam, Susanna, Sebastian Hultin, John Preston, and Scott Campbell. "Temporal Change in Blood Group after Bone Marrow Transplant: A Case of Successful ABO-Incompatible Deceased Donor Transplant." Case Reports in Transplantation 2020 (July 24, 2020): 1–4. http://dx.doi.org/10.1155/2020/7461052.

Full text
Abstract:
ABO-incompatible kidney transplantation has been successfully utilised in a deceased donor and living donor kidney transplantation to improve organ utilisation and decrease waiting times. We describe a case of a successful, unanticipated ABO-incompatible donation after cardiac death (DCD) kidney transplant in a patient who had a previous ABOi haematopoietic stem cell transplant (HSCT) and had reverted to his original blood group B, after matching as a blood group A recipient with a blood group A donor. The recipient was unsensitized with a cPRA which was 0% and no donor-specific antibodies and
APA, Harvard, Vancouver, ISO, and other styles
7

van Agteren, Madelon, Willem Weimar, Annelies E. de Weerd, et al. "The First Fifty ABO Blood Group Incompatible Kidney Transplantations: The Rotterdam Experience." Journal of Transplantation 2014 (2014): 1–6. http://dx.doi.org/10.1155/2014/913902.

Full text
Abstract:
This study describes the single center experience and long-term results of ABOi kidney transplantation using a pretransplantation protocol involving immunoadsorption combined with rituximab, intravenous immunoglobulins, and triple immune suppression. Fifty patients received an ABOi kidney transplant in the period from 2006 to 2012 with a follow-up of at least one year. Eleven antibody mediated rejections were noted of which 5 were mixed antibody and cellular mediated rejections. Nine cellular mediated rejections were recorded. Two grafts were lost due to rejection in the first year. One-year g
APA, Harvard, Vancouver, ISO, and other styles
8

Andenna, Gabriele Gualtiero, Marilena Gregorini, Chiara Elena, et al. "Persistent Neutropenia after ABOi Kidney Transplantation: A Case Report." Transplantology 2, no. 2 (2021): 183–90. http://dx.doi.org/10.3390/transplantology2020017.

Full text
Abstract:
Post-transplant neutropenia (PTN) is frequently reported in the first-year after transplantation. Although prevalence and clinical consequences are widely described, there are no guidelines to manage diagnosis and treatment. We report here a case of persistent PTN occurred in a patient undergoing a kidney transplant from an AB0-incompatible living donor. The desensitization protocol consisted of Rituximab administration and immunoadsorption while the pre-transplant protocol, which was initiated 14 days before the transplant, included Tacrolimus, Mofetil Mycophenolate (MMF), antimicrobial and a
APA, Harvard, Vancouver, ISO, and other styles
9

Markiewicz-Kijewska, Małgorzata, Piotr Kaliciński, Juan Torres Canizales, et al. "ABO Incompatible Liver Transplantation in Children: A 20 Year Experience from Centres in the TransplantChild European Reference Network." Children 8, no. 9 (2021): 760. http://dx.doi.org/10.3390/children8090760.

Full text
Abstract:
An increasing number of AB0-incompatible (AB0i) liver transplantations (LT) are being undertaken internationally in recent years due to organ shortages and the need for urgent transplantation. The aim of our study was establish the value of ABOi LT from available retrospective results of AB0i pediatric liver transplantations performed in European reference centers now belonging to the TransplantChild, European Reference Network (ERN). Data from medical records were analyzed, including demographic data, diagnosis, urgency of transplantation, time on the waiting list, PELD/MELD score, desensitiz
APA, Harvard, Vancouver, ISO, and other styles
10

L, Bahena-Carrera. "Donor exchange programs and ABO incompatible transplant. Change in the traditional view of kidney transplantation in Mexico." Revista de Sanidad Militar 72, no. 2 (2018): 133–40. http://dx.doi.org/10.56443/rsm.v72i2.164.

Full text
Abstract:
There are numerous studies that demonstrate the superiority in terms of survival and quality of life of the transplant as a renal replacement therapy compared with hemodialysis and peritoneal dialysis. National and global waiting lists increase disproportionately in relation to the number of transplants performed and the different governments should institute measures to guarantee the selfsuffi ciency of organs in each country and does the donor Exchange programs and the ABOi resources already tested in different parts of the world with adequate safety and effectiveness that can improve the ra
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "ABOi transplant"

1

Luciene, Della Libera Miguel. "Associação entre o sistema histo-sanguíneo ABO e mucosite oral." Faculdade de Medicina de São José do Rio Preto, 2016. http://hdl.handle.net/tede/405.

Full text
Abstract:
Submitted by Carvalho Dias João Paulo (joao.dias@famerp.br) on 2018-04-04T14:58:22Z No. of bitstreams: 1 lucienedlmiguel_dissert.pdf: 1447414 bytes, checksum: 582a83d74f76a4f73fb4a4901c2660c6 (MD5)<br>Made available in DSpace on 2018-04-04T14:58:22Z (GMT). No. of bitstreams: 1 lucienedlmiguel_dissert.pdf: 1447414 bytes, checksum: 582a83d74f76a4f73fb4a4901c2660c6 (MD5) Previous issue date: 2016-06-08<br>Introduction: Oral mucositis is one of the most frequent diseases resulting from the side effects of Chemotherapy and Radiotherapy. In addition to compromising the quality of life, it increase
APA, Harvard, Vancouver, ISO, and other styles
2

Dimova, Dilyana [Verfasser], and Stefan [Akademischer Betreuer] Zschiedrich. "10 Jahre ABO-inkompatible Nierentransplantation in Freiburg: Auswertung der Langzeitergebnisse im Hinblick auf Transplantat- und Patientenüberleben und Transplantatfunktion." Freiburg : Universität, 2016. http://d-nb.info/112264776X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Paz, Alessandra Aparecida. "Características dos doadores de medula óssea e seu impacto no desfecho dos pacientes submetidos a transplante alogênico no Hospital de Clinicas de Porto Alegre." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2015. http://hdl.handle.net/10183/118328.

Full text
Abstract:
Introdução: O Transplante de Célula Tronco Hematopoiética (TCTH) é um tratamento potencialmente curativo para muitas desordens hematológicas. A disparidade HLA entre doador e receptor é um fator crítico para os resultados do TCTH. No entanto novas evidencias tem demonstrado que outros fatores como a fonte de célula tronco, o tipo de condicionamento e fatores relacionados aos doadores, entre eles o sexo, a idade e o status sorológico para Citomegalovirus (CMV) podem influenciar os desfechos do procedimento. Objetivo: Avaliar as características dos doadores de medula óssea e seu impacto nos desf
APA, Harvard, Vancouver, ISO, and other styles
4

Cordeiro, Beatriz Isabel Quitério. "Transplantação Hepática Pediátrica por Dador ABO Incompatível." Master's thesis, 2020. http://hdl.handle.net/10316/97856.

Full text
Abstract:
Trabalho Final do Mestrado Integrado em Medicina apresentado à Faculdade de Medicina<br>Introdução: O transplante hepático (TRH) ABO incompatível (ABOi) eletivo tem sido utilizado de forma crescente em alguns centros, particularmente com recurso a dador vivo. Devido a avanços nos regimes imunossupressores (ISS) do recetor pré-TRH, estão descritos resultados equiparáveis aos do TRH com dador compatível (ABOc). Em Portugal, o TRH ABOi mantém-se reservado para situações emergentes, onde não é possível essa preparação, estando geralmente associado a pior prognóstico.Materiais e Métodos: Com o obje
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "ABOi transplant"

1

Márquez-Peláez, Sergio, Juan Antonio Blasco-Amaro, and Mª José Aguado-Romeo. Incompatible living-donor kidney transplantation (an update). AETSA Área de Evaluación de Tecnologías Sanitarias de Andalucía, Fundación Progreso y salud. Consejería de Salud y Familias. Junta de Andalucía, 2022. http://dx.doi.org/10.52766/kpnf6027.

Full text
Abstract:
Background This report responds to a need to update the available information about incompatible living-donor kidney transplantation (LDKT) previously published in 2014 which, based on 14 case series and 1 cohort study, concluded that this type of transplants could be a therapeutic option with survival, graft and patient outcomes, adequate and similar to a compatible living-donor kidney transplant, however, these report only included ABO-incompatible information. Objective The purpose of the report is to provide updated evidence on effectiveness and safety in terms of graft survival and surviv
APA, Harvard, Vancouver, ISO, and other styles
2

Sternbach, Marion. Apheresis in the ICU. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0268.

Full text
Abstract:
This chapter describes therapeutic plasma exchange, as well as cytapheresis for hyperleukocytosis and essential thrombocythemia, as well as harvesting haematological stem cells (HSC) for transplantation. Instrumentation and techniques are mostly density centrifugation, much less column adsorption for antibodies or membrane filtration for noxious molecules. Pathophysiology of apheresis is dealt with in great detail with emphasis on prevention and treatment of side effects, much more critical in the intensive care unit (ICU) setting. Main manifestations are: hypocalcaemia due to chelation by ant
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "ABOi transplant"

1

Jha, Pranaw Kumar, and Sidharth Kumar Sethi. "Pediatric ABO-Incompatible Renal Transplant." In Pediatric Solid Organ Transplantation. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-6909-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wang, Jina, and Ruiming Rong. "Mechanism Development of Accommodation and Tolerance in Transplant." In ABO-incompatible Organ Transplantation. Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-3399-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sharma, Sanjeev Kumar. "ABO Mismatched Stem Cell Transplant and Related Complications." In Basics of Hematopoietic Stem Cell Transplant. Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-19-5802-1_52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ota, K., K. Takahashi, T. Agishi, et al. "Multicentre trial of ABO-incompatible kidney transplantation." In Transplant International Official Journal of the European Society for Organ Transplantation. Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77423-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Butani, Lavjay. "Increasing Kidney Transplant Availability: Live Donation, Paired Donation, and Transplant Across ABO and HLA Barriers." In Solid Organ Transplantation in Infants and Children. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-08049-9_31-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Butani, Lavjay. "Increasing Kidney Transplant Availability: Live Donation, Paired Donation, and Transplant Across ABO and HLA Barriers." In Solid Organ Transplantation in Infants and Children. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-07284-5_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jordan, Stanley C., Alice Peng, and Ashley A. Vo. "Therapeutic Strategies in Management of the Highly HLA-Sensitized and ABO-Incompatible Transplant Recipients." In Contributions to Nephrology. KARGER, 2008. http://dx.doi.org/10.1159/000170864.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pavlovic, Mirjana, and Bela Balint. "The HLA and ABO Systems in the View of Stem Cell Transplant (HLA Typization: Choice of Donors)." In SpringerBriefs in Electrical and Computer Engineering. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-5505-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ullah, Asad, and Khalid AlMeshari. "Desensitization in Solid Organ Transplantation." In Biomedical Engineering. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.113262.

Full text
Abstract:
Solid organ transplantation (SOT) has revolutionized the management of end-stage organ disease. Human Leukocyte antigen (HLA) sensitization and ABO incompatibility (ABOi) pose formidable barrier to SOT. The risk of acute rejection is high. They wait longer for compatible organs than their counterparts do. Furthermore, the graft and patient survival are suboptimal in incompatible transplants. Access to SOT could be promoted in this population by prioritizing them to well-matched organs in the allocation system via acceptable mismatch or paired donation programs. If these strategies fail to achi
APA, Harvard, Vancouver, ISO, and other styles
10

L, Mr Tamilselvan. "RECENT ADVANCEMENT IN RENAL TRANSPLANTATION WITH ABO INCOMPATIBLE PATIENTS USING IMMUNOADSORPTION." In Futuristic Trends in Medical Sciences Volume 3 Book 9. Iterative International Publisher, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bfms9p1ch16.

Full text
Abstract:
ABO blood group incompatibility (ABO-I), which carries a high risk of acute antibody-mediated rejection and graft loss, was formerly thought to be a strict no-no for kidney transplantation. ABO-incompatible living donor kidney transplantation has been done due to the significant lack of deceased donors. Novel techniques developed in recent years to lower anti-donor antibodies have made it possible to successfully transplant patients across the ABO barrier. The majority of preconditioning treatments used in Europe are based on IA methods using antigen-specific columns. Commercially available an
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "ABOi transplant"

1

Santos, Joice Rodrigues Dos, Paula Beatriz Pereira, and Victoria Regina Dos Santos. "TRANSPLANTES COM E SEM COMPATIBILIDADE ABO: UMA REVISÃO DA LITERATURA." In II Congresso Brasileiro de Hematologia Clínico-laboratorial On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/hematoclil/27.

Full text
Abstract:
Introdução: O Transplante de órgãos é um marco no âmbito cientifico, desde sua primeira realização com sucesso os transplantes têm sido feitos com alta margem de sucesso e suas técnicas tem sido aprimoradas. O grande êxtase do transplante se deve ao fato de não estar restringido apenas a um órgão, ou seja, há possibilidade de se transplantar outras variedades de órgãos e tecidos podendo ser eles, células, partes ou segmentos de Órgãos ou até mesmo órgão inteiros (por exemplo, um coração). O Processo de Transplante requer uma complexa concórdia de técnicas cirúrgicas e especialidades médicas, s
APA, Harvard, Vancouver, ISO, and other styles
2

Chisaguano, L. C. R. "PERFIL EPIDEMIOLÓGICO DOS PACIENTES EM LISTA DE ESPERA PARA TRANSPLANTE CARDIACO PEDIATRICO E CARDIOPATIAS CONGÊNITAS NO ADULTO NO INSTITUTO DO CORAÇÃO (2014-2019) SÃO PAULO – BRASIL." In ANAIS DO XVII CONGRESSO BRASILEIRO DE TRANSPLANTES; XIX CONGRESSO LUSO BRASILEIRO DE TRANSPLANTES; XVI ENCONTRO DE ENFERMAGEM EM TRANSPLANTES E FÓRUM DE HISTOCOMPATIBILIDADE DA ABHI. Associação Brasileira de Transplantes de Órgãos, 2021. http://dx.doi.org/10.53855/bjt.v24isuplementar.463.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Conceição, GC, TB Moscato, and L. Fraga. "BAIXA EXPRESSÃO ANTIGÊNICA NA DETERMINAÇÃO DE TIPAGEM SANGUÍNEA DO SISTEMA ABO." In Resumos do 54º Congresso Brasileiro de Patologia Clínica/Medicina Laboratorial. Zeppelini Editorial e Comunicação, 2022. http://dx.doi.org/10.5327/1516-3180.140s1.5608.

Full text
Abstract:
Objetivo: Este relato de caso tem como objetivo alertar os profissionais da saúde que trabalham no processo da determinação de tipagem sanguínea sobre a importância do uso de metodologias com boa especificidade e sensibilidade, o controle de qualidade rígido e o uso obrigatório de prova direta e reversa na determinação do grupo sanguíneo do sistema ABO, conforme recomendação da RDC 34, de 11 de junho de 2014. Método: Na rotina laboratorial do setor de imuno-hematologia do Laboratório de Análises Clínicas da APAE-Salvador, utiliza-se a suspensão de hemácias a 2% na prova direta e plasma em EDTA
APA, Harvard, Vancouver, ISO, and other styles
4

Saville, Kirsty, Julie Jeffery, and Katie McGoohan. "P57 An innovative way of working within the Covid 19 Pandemic trialling the use of the Eldon Blood Typing Kit for ABO and Rh blood grouping within the Living Donor Liver Transplant Program at Leeds Teaching Hospitals." In Abstracts of the British Association for the Study of the Liver Annual Meeting, 20–23 September 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-basl.108.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!